GlassScriptPhysician profile
Bradley Hale Byrne
NPI 1558582668
$1,146.42
in general payments reported to CMS, 2019-2025
22 companies · $424 in 2025
The $424 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.47 · 2020: $14.84 · 2021: $220 · 2022: $105 · 2023: $98.60 · 2024: $215 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $737.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $184.52 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $181.84 | 2019-2024 | Dupixent |
| Ucb, INC. | $175.76 | 2023-2025 | Bimzelx, Cimzia |
| Glaxosmithkline, LLC. | $147.21 | 2021-2025 | Nucala |
| Aurinia Pharma U.S., INC. | $52.66 | 2023-2025 | Lupkynis |
| Novartis Pharmaceuticals Corporation | $43.29 | 2024-2025 | |
| Janssen Biotech, INC. | $37.53 | 2024-2025 | Tremfya |
| Genzyme Corporation | $34.95 | 2025 | |
| Stryker Corporation | $33.07 | 2019 | |
| Blueprint Medicines Corporation | $29.28 | 2024 | Ayvakit |
| Celltrion USA INC. | $28.54 | 2025 | Vegzelma |
| Medtronic, INC. | $25.53 | 2022 | |
| Aerin Medical INC. | $24.71 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.75 | 2025 | Takhzyro |
| Genentech USA, INC. | $19.50 | 2025 | Xolair |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $18.75 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $17.43 | 2025 | Neffy |
| Amgen INC. | $16.52 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.24 | 2023 | Saphnelo |
| Tactile Systems Technology INC | $14.84 | 2020 | |
| Arbor Pharmaceuticals, INC. | $12.32 | 2019 | |
| Merck Sharp & Dohme LLC | $12.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Byrne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.